The University of Mississippi
School of Pharmacy Department of Medicinal Chemistry: Prof. Christopher McCurdy

Consulting of Professor Christopher R. McCurdy


SERVICE AS SCIENTIFIC REFEREE

Invited National Institutes of Health Referee (Ad-Hoc)

National Institute on Drug Abuse – RFA 12-005 Medications Development Program Projects for Substance-Related Disorders (P01), October, 18-19, 2011.
National Institute on Drug Abuse – Special Emphasis Panel ZDA1-JXR-D(06). RFA 12-001 New Molecular Entities to Treat Substance Use Disorders, May 24, 2011.
National Institute on Drug Abuse – Special Emphasis Panel ZDA1 LXF-L (01), March 22, 2011.
National Institute of Mental Health – National Cooperative Drug Discovery sand Development Groups (NCDDDG) Special Emphasis Panel ZMH1 ERB-C (04), March 10, 2011.
National Institutes of Health Center for Scientific Review – Drug Discovery Special Emphasis Panel/Scientific Review Group 2011/01 ZRG1 MDCN-B (91) S, November 9-10, 2010.
National Institute of Diabetes and Digestive and Kidney Diseases – Cystic Fibrosis Research and Translational Core Centers ZDK1 GRB-W (M2).  April 7-8, 2010.
National Institute on Drug Abuse – Special Emphasis Panel ZDA1 LXF-L (01), March 21, 2010.
National Institute on Drug Abuse – Member Conflict: Drug Discovery Panel ZRG1 MDCN-B (02), March 9-10, 2010.
National Institute of Mental Health – National Cooperative Drug Discovery sand Development Groups (NCDDDG) Special Emphasis Panel ZMH1 ERB-C (03), March 1, 2010.
National Institute of Allergy and Infectious Disease – Special Emphasis Panel ZAI1 LR-M (M1) – Partnerships for Development of Therapeutics and Diagnostics for Drug-Resistant Bacteria and Eukaryotic Parasites (R01 and R43/44), January 26-27, 2010.
National Institute on Drug Abuse – SBIR contract review Panel RFC No. N43DA-10-7774 – Rapid and sensitive method for the determination of Nicotine and its metabolites in biological fluids, January 12-14, 2010.
National Institute on Drug Abuse – SBIR contract review panel RFC No. N43DA-10-2218 – New Technologies:  Integrating Data From Prescription Monitoring Program(s) to Current Clinical Practice, December 16, 2009.
National Institutes of Health Center for Scientific Review – Drug Discovery for Neurodegenerative Diseases Special Emphasis Panel ZRG1 MDCN-B (91) S, November 3-4, 2009.
National Institutes of Health Chemical and Bioanalytical Sciences Fellowship Study Section (F04A), June 18-19, 2009.
National Institute on Drug Abuse – Contract Review on GMP Synthesis of Bulk Drug Substances (N01DA-9-8881), May 13, 2009.
National Institute on Drug Abuse – Special Emphasis Panel ZDA1 LXF-L (01), March 30, 2009.
National Institutes of Health Center for Scientific Review – Drug Discovery for Neurodegenerative Diseases Special Emphasis Panel ZRG1 MDCN-B (91), February 19-20, 2009.
National Institute on Drug Abuse – Contract Review on Non-clinical ADME Studies (N01DA-9-8883), December 11, 2008.
National Institute on Drug Abuse – Contract Review on the quantification of drugs of abuse and related substances in biological specimens (N01DA-9-7767), August 6, 2008
National Institutes of Health Chemical and Bioanalytical Sciences Fellowship Study Section (F04A) ZRG1 F04A-T (20)L, June 26, 2008
National Institute for Research Resources – Science Education Partnership Award (SEPA) Special Emphasis Panel ZRR1 SEPA-9 01, March 2007
National Institute for Research Resources – Science Education Partnership Award (SEPA) Special Emphasis Panel ZRR1 SEPA-9 01, March 2006
National Institute of Allergy and Infectious Disease – Special Emphasis Panel ZAI-1-LR-M-M1, January/February 2006
National Institute of Diabetes and Digestive and Kidney Diseases – Special Emphasis Panel ZDK1 GRB-6 (M1), April 19, 2005
National Institute of Allergy and Infectious Disease-sponsored RFA, 2004

Invited Austrian Science Fund (FWF) Referee

Translational Research Programme (TRP) – November 27, 2009 (contact Silvia Spitzer Silvia.Spitzer@fwf.ac.at)

Invited Journal Referee

Medicinal Chemistry Research 1998 – present
Expert Opinion on Therapeutic Patents, 1998
Journal of Medicinal Chemistry 1999 – present
Biopolymers (Peptide Science), 2003 – present
Current Medicinal Chemistry, 2003 – present
Journal of Natural Products, 2003 – present
Bioorganic & Medicinal Chemistry Letters, 2004 – present
Molecules, 2004 – present
Neurochemical Research, 2004 – present
Journal of Pharmacy & Pharmaceutical Sciences, 2004 – present
Current Topics in Medicinal Chemistry, 2004 – present
Synapse, 2005 – present
Life Sciences, 2005 – present
Peptides, 2005 – present
Organic Letters, 2005 – present
Journal of Combinatorial Chemistry, 2005 – present
Proceedings of the National Academy of Science, USA, 2005 – present
Letters in Organic Chemistry, 2006
Chimica Oggi (Chemistry Today), 2006
Journal of Pharmacy and Pharmacology, 2006
Combinatorial Chemistry and High Throughput Screening, 2006
American Journal of Pharmaceutical Education, 2006 – present
Tetrahedron, 2007 – present
Archiv der Pharmazie, 2007 – present
Chemical Reviews, 2007 – present
Tetrahedron Letters, 2007 – present
Journal of Pharmacology and Experimental Therapeutics, 2007 – present
The Open Medicinal Chemistry Journal, 2008 – present
Current Bioactive Compounds, 2008 – present
Pharmacology, Biochemistry and Behavior, 2008 – present
Journal of Computer Information and Modeling, 2008 – present
British Journal of Pharmacology, 2008 – present
Bioorganic Medicinal Chemistry, 2008 – present
Molecular Pharmaceutics, 2008 – present
Journal of the American Chemical Society, 2008 – present
Neuropsychopharmacology, 2008 – present
Synthesis, 2008 – present
Future Medicinal Chemistry, 2009 – present
Protein and Peptide Letters, 2009 – present
Journal of Computer-Aided Molecular Design, 2009 – present
Journal of Molecular Graphics and Modeling, 2009 – present
BMC Research Notes, 2009 – present
Neuroscience Letters, 2009 – present
ACS Chemical Neuroscience, 2009 – present
Journal of Structural Biology, 2009 – 2010   
ACS Medicinal Chemistry Letters, 2010 – present
Current Pharmaceutical Design, 2010 – present
ACS Combinatorial Science, 2010 – present
The Journal of Physical Chemistry, 2011 – present
Journal of Antibiotics, 2011
Molecular Pharmaceutics, 2011

Editorial Appointments

New Trends Editor, Medicinal Chemistry Research, Springer, 2002 – 2010
Senior Editorial Board, Molecular Conceptor, Synergix, Ltd., 2005 – Present
Editorial Advisory Board, Current Topics in Medicinal Chemistry, Bentham, 2006 – 2009
Editorial Board, Pharmacologyonline, 2006 – Present
Editorial Board, Perspectives in Medicinal Chemsitry, Libertas Academica, 2007 – Present
Editorial Board, The Open Medicinal Chemistry, Bentham, 2007 – Present
Editorial Board, The Open Enzyme Inhibition Journal, Bentham, 2008 – Present
Editorial Board, Current Bioactive Compounds, Bentham, 2008 – Present
Editorial Board, Future Medicinal Chemistry, Future Science Group, 2008 – Present
Senior Editor, Medicinal Chemistry Research, Springer, 2011 – Present
Editorial Advisory Board, Journal of Medicinal Chemsitry, ACS Publications, 2011 – Present
Guest Editor, Current Topics in Medicinal Chemistry, Bentham, 2011
Editorial Board, World Journal of Pharmacology, Baishideng Publishing Group, 2011 – Present
Associate Editor (Ad Hoc), AAPS PharmSci Tech, AAPS Publishing, 2011

Expert Witness Legal Consultancy

Sterne, Kessler, Goldstein & Fox, 09/2007 – 03/2008